Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 4 | |
Outperform | 5 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 9 analysts offering 12 month price targets for Voyager Therapeutics Inc have a median target of 18.00, with a high estimate of 30.00 and a low estimate of 7.00. The median estimate represents a 231.49% increase from the last price of 5.43.
High | 452.5% | 30.00 |
Med | 231.5% | 18.00 |
Low | 28.9% | 7.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 26, 2025.
Average growth rate | +10.56% |
Average growth rate | +35.98% |
More ▼
Revenue history & estimates in USD
Average growth rate | +452.10% |
Average growth rate | +126.57% |
More ▼